21 November 2024

Last updated: Monday 18 November 2024

Research Directory

Failure rate rises for late-stage oncology studies

A window onto oncology drug success rates

Ethics panels need to keep pace with trial reform

Highlights of the new EU Clinical Trials Regulation

What next for the EMA's transparency policy?

Alkermes pioneers trial design in depression

Debate heats up over access to clinical trial data

The Special Protocol Assessment: Regulatory success is not guaranteed

A new era for HDAC inhibitors?

Success and failure in late-stage oncology